Molecular Psychiatry - Table of Contents alert Volume 23 Issue 4

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 23, Issue 4 (April 2018) In this issue Image Letters to the Editor Perspective Mechanisms of Drug Action Original Articles Corrigendum Also new AOP   Image Human cerebral organoids reveal deficits in neurogenesis and neuronal migration in MeCP2-deficient neural progenitors N Mellios, D A Feldman, S D Sheridan, J P K Ip, S Kwok et al. Molecular Psychiatry 2018 23 :791 - 791; March 22, 2018; 10.1038/mp.2018.5   Abstract | Full Text Letters to the Editor A comparative expression analysis of isocitrate dehydrogenase-3 gene and protein levels in postmortem brain tissues from subjects with bipolar disorder G Scola, A C Andreazza & L T Young Molecular Psychiatry 2017 23 :792 - 793; July 25, 2017; 10.1038/mp.2017.149   Abstract | Full Text Paternal experience impacts cognitive function in offspring: a pre-existing concept J Bohacek, U Weber-Stadlbauer & I M Mansuy Molecular Psychiatry 2017 23 :794 - 795; July 25, 2017; 10.1038/mp.2017.162   Abstract | Full Text Perspective When should governments increase the supply of psychiatric beds? S Allison, T Bastiampillai, J Licinio, D A Fuller, N Bidargaddi et al. Molecular Psychiatry 2017 23 :796 - 800; July 11, 2017; 10.1038/mp.2017.139   Abstract | Full Text Mechanisms of Drug Action Mechanisms of ketamine action as an antidepressant P Zanos & T D Gould Molecular Psychiatry 2018 23 :801 - 811; March 13, 2018; 10.1038/mp.2017.255   Abstract | Full Text Original Articles Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling L Cavalleri, E Merlo Pich, M J Millan, C Chiamulera, T Kunath et al. Molecular Psychiatry 2017 23 :812 - 823; November 21, 2017; 10.1038/mp.2017.241   Abstract | Full Text Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression I Esterlis, N DellaGioia, R H Pietrzak, D Matuskey, N Nabulsi et al. Molecular Psychiatry 2017 23 :824 - 832; April 11, 2017; 10.1038/mp.2017.58   Abstract | Full Text A novel 5HT3 receptor–IGF1 mechanism distinct from SSRI-induced antidepressant effects M Kondo, Y Koyama, Y Nakamura & S Shimada Molecular Psychiatry 2017 23 :833 - 842; April 25, 2017; 10.1038/mp.2017.87   Abstract | Full Text A connectomic approach for subcallosal cingulate deep brain stimulation surgery: prospective targeting in treatment-resistant depression P Riva-Posse, K S Choi, P E Holtzheimer, A L Crowell, S J Garlow et al. Molecular Psychiatry 2017 23 :843 - 849; April 11, 2017; 10.1038/mp.2017.59   Abstract | Full Text Depression, telomeres and mitochondrial DNA: between- and within-person associations from a 10-year longitudinal study J E Verhoeven, D Révész, M Picard, E E Epel, O M Wolkowitz et al. Molecular Psychiatry 2017 23 :850 - 857; March 28, 2017; 10.1038/mp.2017.48   Abstract | Full Text Early life adversity and telomere length: a meta-analysis K K Ridout, M Levandowski, S J Ridout, L Gantz, K Goonan et al. Molecular Psychiatry 2017 23 :858 - 871; March 21, 2017; 10.1038/mp.2017.26   Abstract | Full Text CK2 regulates 5-HT4 receptor signaling and modulates depressive-like behavior J Castello, B LeFrancois, M Flajolet, P Greengard, E Friedman et al. Molecular Psychiatry 2017 23 :872 - 882; November 21, 2017; 10.1038/mp.2017.240   Abstract | Full Text Calhm2 governs astrocytic ATP releasing in the development of depression-like behaviors M Jun, Q Xiaolong, Y Chaojuan, P Ruiyuan, W Shukun et al. Molecular Psychiatry 2017 23 :883 - 891; November 28, 2017; 10.1038/mp.2017.229   Abstract | Full Text Perisomatic changes in h-channels regulate depressive behaviors following chronic unpredictable stress C S Kim, D H Brager & D Johnston Molecular Psychiatry 2017 23 :892 - 903; April 18, 2017; 10.1038/mp.2017.28   Abstract | Full Text Translational profiling of stress-induced neuroplasticity in the CA3 pyramidal neurons of BDNF Val66Met mice J D Gray, T G Rubin, J F Kogan, J Marrocco, J Weidmann et al. Molecular Psychiatry 2016 23 :904 - 913; December 13, 2016; 10.1038/mp.2016.219   Abstract | Full Text Optogenetic silencing of a corticotropin-releasing factor pathway from the central amygdala to the bed nucleus of the stria terminalis disrupts sustained fear A Asok, A Draper, A F Hoffman, J Schulkin, C R Lupica et al. Molecular Psychiatry 2017 23 :914 - 922; April 25, 2017; 10.1038/mp.2017.79   Abstract | Full Text Bipolar mood cycles and lunar tidal cycles T A Wehr Molecular Psychiatry 2017 23 :923 - 931; January 24, 2017; 10.1038/mp.2016.263   Abstract | Full Text Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group D P Hibar, L T Westlye, N T Doan, N Jahanshad, J W Cheung et al. Molecular Psychiatry 2017 23 :932 - 942; May 02, 2017; 10.1038/mp.2017.73   Abstract | Full Text Early neuromodulation prevents the development of brain and behavioral abnormalities in a rodent model of schizophrenia R Hadar, L Bikovski, M L Soto-Montenegro, J Schimke, P Maier et al. Molecular Psychiatry 2017 23 :943 - 951; April 04, 2017; 10.1038/mp.2017.52   Abstract | Full Text Interactome analysis reveals ZNF804A, a schizophrenia risk gene, as a novel component of protein translational machinery critical for embryonic neurodevelopment Y Zhou, F Dong, T A Lanz, V Reinhart, M Li et al. Molecular Psychiatry 2017 23 :952 - 962; September 19, 2017; 10.1038/mp.2017.166   Abstract | Full Text Genetic risk for schizophrenia and psychosis in Alzheimer disease M A A DeMichele-Sweet, E A Weamer, L Klei, D T Vrana, D J Hollingshead et al. Molecular Psychiatry 2017 23 :963 - 972; May 02, 2017; 10.1038/mp.2017.81   Abstract | Full Text Mapping autosomal recessive intellectual disability: combined microarray and exome sequencing identifies 26 novel candidate genes in 192 consanguineous families R Harripaul, N Vasli, A Mikhailov, M A Rafiq, K Mittal et al. Molecular Psychiatry 2017 23 :973 - 984; April 11, 2017; 10.1038/mp.2017.60   Abstract | Full Text Copy number elevation of 22q11.2 genes arrests the developmental maturation of working memory capacity and adult hippocampal neurogenesis S Boku, T Izumi, S Abe, T Takahashi, A Nishi et al. Molecular Psychiatry 2017 23 :985 - 992; August 22, 2017; 10.1038/mp.2017.158   Abstract | Full Text ASD restricted and repetitive behaviors associated at 17q21.33: genes prioritized by expression in fetal brains R M Cantor, L Navarro, H Won, R L Walker, J K Lowe et al. Molecular Psychiatry 2017 23 :993 - 1000; May 23, 2017; 10.1038/mp.2017.114   Abstract | Full Text Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder M V Lombardo, H M Moon, J Su, T D Palmer, E Courchesne et al. Molecular Psychiatry 2017 23 :1001 - 1013; March 21, 2017; 10.1038/mp.2017.15   Abstract | Full Text A new locus regulating MICALL2 expression was identified for association with executive inhibition in children with attention deficit hyperactivity disorder L Yang, S Chang, Q Lu, Y Zhang, Z Wu et al. Molecular Psychiatry 2017 23 :1014 - 1020; April 18, 2017; 10.1038/mp.2017.74   Abstract | Full Text Astrocytic water channel aquaporin-4 modulates brain plasticity in both mice and humans: a potential gliogenetic mechanism underlying language-associated learning J Woo, J E Kim, J J Im, J Lee, H S Jeong et al. Molecular Psychiatry 2017 23 :1021 - 1030; June 27, 2017; 10.1038/mp.2017.113   Abstract | Full Text Lipocalin-2 regulates adult neurogenesis and contextual discriminative behaviours A C Ferreira, T Santos, B Sampaio-Marques, A Novais, S D Mesquita et al. Molecular Psychiatry 2017 23 :1031 - 1039; May 09, 2017; 10.1038/mp.2017.95   Abstract | Full Text Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex D Scheggia, E Zamberletti, N Realini, M Mereu, G Contarini et al. Molecular Psychiatry 2017 23 :1040 - 1050; June 20, 2017; 10.1038/mp.2017.126   Abstract | Full Text MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling N Mellios, D A Feldman, S D Sheridan, J P K Ip, S Kwok et al. Molecular Psychiatry 2017 23 :1051 - 1065; April 25, 2017; 10.1038/mp.2017.86   Abstract | Full Text Brain-derived neurotrophic factor Val66Met genotype and ovarian steroids interactively modulate working memory-related hippocampal function in women: a multimodal neuroimaging study S-M Wei, E B Baller, P D Kohn, J S Kippenhan, B Kolachana et al. Molecular Psychiatry 2017 23 :1066 - 1075; April 18, 2017; 10.1038/mp.2017.72   Abstract | Full Text The joint impact of cognitive performance in adolescence and familial cognitive aptitude on risk for major psychiatric disorders: a delineation of four potential pathways to illness K S Kendler, H Ohlsson, R S E Keefe, K Sundquist & J Sundquist Molecular Psychiatry 2017 23 :1076 - 1083; April 18, 2017; 10.1038/mp.2017.78   Abstract | Full Text Structural alterations within cerebellar circuitry are associated with general liability for common mental disorders A L Romer, A R Knodt, R Houts, B D Brigidi, T E Moffitt et al. Molecular Psychiatry 2017 23 :1084 - 1090; April 11, 2017; 10.1038/mp.2017.57   Abstract | Full Text Corrigendum Calhm2 governs astrocytic ATP releasing in the development of depression-like behaviors M Jun, Q Xiaolong, Y Chaojuan, P Ruiyuan, W Shukun et al. Molecular Psychiatry 2018 23 :1091 - 1091; January 09, 2018; 10.1038/mp.2017.254   Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Molecular Psychiatry. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.